Related Experiment Video
Updated: Mar 24, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Unplugging JAK/STAT in Chronic Myelomonocytic Leukemia
1Inserm U1170, Gustave Roussy, Villejuif, France. Faculty of Medicine, University Paris-Sud, Le Kremlin-Bicêtre, France. Eric.SOLARY@gustaveroussy.fr.
Abstract:
The proliferative component of chronic myelomonocytic leukemia, related to an increased sensitivity of myeloid progenitors to granulocyte macrophage-colony stimulating factor, suggests dedicated therapeutic approaches. In this issue, ruxolitinib, a JAK1 and -2 inhibitory drug, is shown to induce objective responses in chronic myelomonocytic leukemia patients. Clin Cancer Res; 22(15); 3707-9. ©2016 AACRSee related article by Padron et al., p. 3746.
More Related Videos
10:21Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
The JAK-STAT Signaling Pathway
Regulation of Hematopoietic Stem Cells